| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/30/2002 | EP1045897B1 Enzyme catalyzed therapeutic agents |
| 01/30/2002 | EP1045681A4 METHOD AND COMPOSITIONS FOR $i(IN SITU) FORMATION OF PROTECTIVE AND/OR MEDICATED FILMS ON BODY TISSUE |
| 01/30/2002 | EP0991409B1 Controlled release pharmaceutical compositions containing tiagabine |
| 01/30/2002 | EP0904050B1 Use of lactic acid esters |
| 01/30/2002 | EP0868183B1 Injectable quinolone formulations |
| 01/30/2002 | EP0857060B1 Method and preparations for stabilizing biological materials by drying methods without freezing |
| 01/30/2002 | EP0819136B1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same |
| 01/30/2002 | EP0814771B1 Improvements in or relating to organic compositions |
| 01/30/2002 | EP0744946B1 Compositions containing micronized nebivolol |
| 01/30/2002 | EP0614355B1 Antitumor vaccines |
| 01/30/2002 | EP0535155B1 Libraries of modified peptides with protease resistance |
| 01/30/2002 | CN1333873A HIV-specfic T-cell induction |
| 01/30/2002 | CN1333694A Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 01/30/2002 | CN1333693A ordered molecualr presentation of antigens, method of preparation and use |
| 01/30/2002 | CN1333690A Method for producing medicaments from plant extracts, in solid form of administration |
| 01/30/2002 | CN1333686A Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions |
| 01/30/2002 | CN1333683A Pharmaceutical composition for modified release insulin sensitiser |
| 01/30/2002 | CN1333682A Storable active substance concentrate with formoterol |
| 01/30/2002 | CN1333680A Oral formulation for gastrointestinal drug delivery |
| 01/30/2002 | CN1333679A Dispersible phospholipid stabilzed microparticles |
| 01/30/2002 | CN1333678A Hepatocyte targeting polyethylene glyco-grafted poly-lysine polymeric gene carrier |
| 01/30/2002 | CN1333677A Composition set and kit for use in intraocular surgery |
| 01/30/2002 | CN1333674A Flavour blend for masking unpleasant taste of zinc compounds |
| 01/30/2002 | CN1333651A Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method |
| 01/30/2002 | CN1333372A Process for preparing potide zinc easy absorbed in human body |
| 01/30/2002 | CN1333018A Medicine for treating immune relative disease of anterior chamber and surface of eye |
| 01/30/2002 | CN1078461C Oestradiol transdermal therapeutic system comprising hydroscopic additives |
| 01/29/2002 | US6342537 Gel for treatment of skin diseases and for disinfection of the skin |
| 01/29/2002 | US6342533 Antidepressants udes for bipolar and attention deficit disorders, hyperactivity, parkinson's disease, epilepsy, eating disorders |
| 01/29/2002 | US6342530 Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt |
| 01/29/2002 | US6342493 Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
| 01/29/2002 | US6342480 Tumor-activated prodrug compounds and treatment |
| 01/29/2002 | US6342477 Remedies for thrombocytopenia |
| 01/29/2002 | US6342251 Compositions for nasal administration |
| 01/29/2002 | US6342250 Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
| 01/29/2002 | US6342245 Compositions of lipid lowering agents |
| 01/29/2002 | US6342244 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides, drugs and liposomes; upon cleavage of the linkage, the ligand |
| 01/29/2002 | US6342241 For sustained release the drug (b) to deliver it into an organism by a syringe, prevents irritation, inflammation |
| 01/29/2002 | US6342234 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 01/29/2002 | US6342226 Administering antigen combined with a particulate vector, the particulate vector consisting of a non-liquid hydrophilic core for increasing the immunogenicity of an antigen |
| 01/29/2002 | US6342223 Conjugate vaccine capable of conferring host immunity to an infection by group b streptococcus which comprises polysaccharide conjugated to protein |
| 01/29/2002 | US6342221 Antibody conjugate compositions for selectively inhibiting VEGF |
| 01/29/2002 | US6342219 As anti-angiogenic and in tumor therapy |
| 01/29/2002 | CA2222567C High viscosity liquid controlled biologically active delivery system |
| 01/29/2002 | CA2216789C Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
| 01/29/2002 | CA2107568C Use of sphingolipids in the preparation of a cosmetic or dermato-pharmaceutical composition for the protection of skin and hair against the harmful effects of atmospheric pollution |
| 01/29/2002 | CA2093206C Biphasic release formulations for lipophilic drugs |
| 01/28/2002 | CA2354110A1 Use of agonists of the prostaglandin ep 3 receptor as a cosmetic agent to mitigate, reduce or stop hair growth |
| 01/28/2002 | CA2352645A1 Compositions for dna transfection |
| 01/24/2002 | WO2002006373A1 Hydrogel films and methods of making and using therefor |
| 01/24/2002 | WO2002006349A1 Gel compositions containing metronidazole |
| 01/24/2002 | WO2002006310A1 Peptide fructose and complex thereof with binding protein |
| 01/24/2002 | WO2002005944A1 Method for encapsulating fine solid particles in the form of microcapsules |
| 01/24/2002 | WO2002005864A1 An implantable or insertable therapeutic agent delivery device |
| 01/24/2002 | WO2002005855A1 Pharmaceutical compositions containing dds compounds |
| 01/24/2002 | WO2002005853A2 Compositions containing alpha-2-adrenergic agonist components |
| 01/24/2002 | WO2002005852A1 Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| 01/24/2002 | WO2002005851A2 Enhancement of the action of central and peripheral nervous system agents |
| 01/24/2002 | WO2002005849A2 Transportation of nucleic acid substances |
| 01/24/2002 | WO2002005844A2 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | WO2002005840A1 Medicinal compositions for promoting fixation of transplanted cells |
| 01/24/2002 | WO2002005836A2 Stimulation of bone growth with thrombin peptide derivatives |
| 01/24/2002 | WO2002005834A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 01/24/2002 | WO2002005822A2 Compositions containing therapeutically active components having enhanced solubility |
| 01/24/2002 | WO2002005815A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | WO2002005812A1 Medicaments for chemotherapeutic treatment of disease |
| 01/24/2002 | WO2002005809A1 Dermal for amino laevulinic acid |
| 01/24/2002 | WO2002005800A2 Compositions for sustained release of analgesic agents, and methods of making and using the same |
| 01/24/2002 | WO2002005790A1 Adhesive preparation |
| 01/24/2002 | WO2002005786A1 Pharmaceutical composition improved in peroral absorbability |
| 01/24/2002 | WO2002005784A1 A medicinal aerosol formulation |
| 01/24/2002 | WO2002005783A1 Water soluble microflake through air-gap and process therefore |
| 01/24/2002 | WO2002005782A2 Stable salts of o-acetylsalicyclic with basic amino acids |
| 01/24/2002 | WO2002005763A1 Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides |
| 01/24/2002 | WO2002005747A2 The process of manufacturing pharmaceutical grade tannates |
| 01/24/2002 | WO2002005746A2 The process of manufacturing pharmaceutical grade tannates |
| 01/24/2002 | WO2002005645A1 Modified serum albumin with reduced affinity for nickel and copper |
| 01/24/2002 | WO2001076553A3 Method and device for enhanced transdermal drug delivery |
| 01/24/2002 | WO2001066132A3 Hiv immune adjuvant therapy |
| 01/24/2002 | WO2001060412A3 Modification of biopolymers for improved drug delivery |
| 01/24/2002 | WO2001053324A3 Novel haptotactic peptides |
| 01/24/2002 | WO2001051071A3 Transepithelial delivery of glp-1 derivatives |
| 01/24/2002 | WO2001041785A3 Enzyme treatment for infection |
| 01/24/2002 | WO2001039744A3 Radiation sensitive liposomes |
| 01/24/2002 | WO2001036595A3 Methods for conditional transgene expression and trait removal in plants |
| 01/24/2002 | WO2001036005A3 Targeted delivery of therapeutic and diagnostic moieties |
| 01/24/2002 | WO2001030336B1 Pharmaceutical formulations comprising resveratrol and use thereof |
| 01/24/2002 | WO2001022936A8 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 01/24/2002 | WO2001017564A3 Enzyme inhibitors |
| 01/24/2002 | WO2001016290A3 Dna encoding the human serine protease eos |
| 01/24/2002 | WO2001015511A3 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 01/24/2002 | WO2001010454A3 Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection |
| 01/24/2002 | WO2001008708A3 Enhanced delivery via serpin enzyme complex receptor ligands |
| 01/24/2002 | WO2001006987A3 Transnasal anticonvulsive compositions and modulated process |
| 01/24/2002 | WO2000078359A3 Compositions for treating chemotherapy-resistant tumor cells |
| 01/24/2002 | US20020010357 Heat resistance dosage forms |
| 01/24/2002 | US20020010208 Dha-pharmaceutical agent conjugates of taxanes |
| 01/24/2002 | US20020010195 Mitochondria protecting agents for treating mitochondria associated diseases |
| 01/24/2002 | US20020010187 5-((4-(3-methyl-4-oxo-3,4-dihydro-2 -quinazolinyl)methoxy)phenylmethyl)thiazolidine-2 ,4-dione or a pharmaceutically acceptable salt thereof |
| 01/24/2002 | US20020010159 Proton pump inhibitors |